Heart Failure in Women
Citations Over TimeTop 12% of 2012 papers
Abstract
Heart failure (HF) has steadily increased in prevalence and affects both males and females equally. Despite this, there has been a significant underrepresentation of women in large scale HF trials. This disparity has lead to a deficit in understanding important gender-based differences in pathophysiology, diagnosis and treatment strategies. We review these gaps and explore a biological basis for varying outcomes. Endogenous estrogen plays an important role in epidemiology and outcome. The administration of exogenous estrogen has had varied success in treatment and is outlined extensively below. Additionally, we highlight unique HF syndromes through pregnancy and important sex-specific issues concerning transplant and mechanical circulatory support. A central theme remains: there is a clear need for increased female recruitment in clinical trials, and more studies exploring the role of gender-based biology in HF treatment.
Related Papers
- → Effect of Cardiac Resynchronization Therapy on Inflammation in Congestive Heart Failure: A Review(2015)12 cited
- Managing heart failure in primary care(1996)
- Congestive heart failure : current clinical issues(1994)
- 에스트로겐/칼슘 혼합요법이 난소절제 쥐의 골대사에 미치는 영향 II. 칼슘, 인 및 질소대사에 관한 연구(1996)
- Clinical observation of heart failure mixture in congestive heart failure:on 30 cases report(2012)